Moreover, DHEA inhibits tumor development and progression in many types of animal models (Boccuzzi et al, 1992; Di Monaco et al, 1997), although the clinical effectiveness of DHEA alone is limited because of a relatively high IC50 level to control G6PD activity and subsequent high oral doses. The gene discussed is G6PD; the disease is neoplasm.